Search - tctmd.com

Displaying 61 - 80 of 2033

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

L.A. McKeown

May 21, 2025

News Conference News ESC Heart Failure 2025

HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM

Todd Neale

May 19, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Daily News

Four-Dimensional Flow CMR Shows Promise in Aortic Stenosis

Yael L. Maxwell

May 13, 2025

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

News Conference News HRS 2025

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

Todd Neale

April 28, 2025

News Conference News CX Symposium 2025

Plant-Derived Compound Shows Early Promise for Small AAAs

L.A. McKeown

April 25, 2025

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

L.A. McKeown

April 15, 2025

News Daily News

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Michael O'Riordan

April 09, 2025

News Conference News EHRA 2025

Positive Results With Volt Pulsed-Field Ablation System

Todd Neale

April 07, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

Caitlin E. Cox

April 01, 2025

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Caitlin E. Cox

March 25, 2025

News Daily News

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Caitlin E. Cox

March 21, 2025

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

Advertisement

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Four-Dimensional Flow CMR Shows Promise in Aortic Stenosis

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

Plant-Derived Compound Shows Early Promise for Small AAAs

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Positive Results With Volt Pulsed-Field Ablation System

TCTMD’s Top 10 Most Popular Stories for March 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content